|
Pharmaceutical industry offers Ottawa $1-billion to scrap pending drug pricing rules, documents show
Monday, November 16th, 2020
The pharmaceutical industry has made a last-ditch $1-billion proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan. 1… to boost local manufacturing and commercialization, and on new programs to improve access to drugs for rare diseases… “The position of the Government of Canada remains unchanged – Canada has among the highest patented medicine prices in the world, and these high prices negatively affect the ability of patients to access new medicines”
Tags: budget, Health, ideology, mental Health, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
Recent Comments